Align Technology Inc

Align Technology, Inc. is a global leader in dental technology and the maker of Invisalign clear aligners. We were initially drawn to Align for its strong competitive position and innovative iTero digital scanning system, which enables clinicians to design more precise treatment plans and enhances the overall patient experience. However, the stock underperformed during the quarter as expectations for a demand rebound did not materialize. Patient conversion rates softened, most notably within the teen segment, where revenue growth slowed to 3%. Given these dynamics, we trimmed our position during the period.

Align Technology, which sells clear aligners for straightening teeth as an alternative to braces, has been negatively impacted by high interest rates that may suppress consumer demand for this big-ticket purchase. In the first half of the year, Align was one of our biggest detractors from performance, down 9.2%. The current economic environment poses challenges for discretionary spending, particularly for products like Align's, which are often considered luxury items. As such, we are cautious about its growth prospects in the near term.

Align Technology has been struggling with slower demand for its orthodontic services as budget- and inflation-conscious consumers reduced discretionary spending. This decline in revenue growth suggests intensifying competition from other clear aligner brands, leading us to redeploy capital from Align into other higher-conviction positions.

Align Technology has been struggling with slower demand for its orthodontic services as budget- and inflation-conscious consumers reduced discretionary spending. This decline in revenue growth suggests intensifying competition from other clear aligner brands, leading us to redeploy capital to other higher-conviction positions.